Shuttle Pharmaceuticals Holdings, Inc.
SHPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, EPS grew 90.6% and free cash flow grew 82.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SHPH
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) P/E ratio
As of 16 October 2026, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trades at a P/E ratio of 0.2×. Over the past ten years it has ranged from 0.0× (March 2026) to 21,000× (April 2026); the current reading is higher than 93% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RMTI Rockwell Medical, Inc. compare | n/m |
| AYTU Aytu BioPharma, Inc. compare | n/m |
| SCYX SCYNEXIS, Inc. compare | n/m |
| TXMD TherapeuticsMD, Inc. compare | n/m |
| IXHL Incannex Healthcare Inc. compare | n/m |
| UPC Universe Pharmaceuticals INC compare | n/m |
| CPHI China Pharma Holdings, Inc. compare | n/m |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | 0.2× |
| ZYBT Zhengye Biotechnology Holding Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)